MEDai Helps Medicare Part D Sponsors Adhere to CMS Medication Therapy Management Initiative
Posted on: Tuesday, 19 May 2009, 07:00 CDT
MEDai's solutions grant Part D benefit sponsors the ability to identify MTM members who meet client-specific requirements as well as stratify patients using CMS mandated rules. The user-friendly applications collect, analyze and report on data that facilitates sponsor adherence to this new initiative. Clients can specify participation criteria; analyze the necessary data; and produce patient encounter documentation, patient and provider communication, and reporting documents.
"MEDai continues to develop solutions that address immediate needs in the payor market," said
About MEDai
MEDai, Inc. is a subsidiary of Elsevier, a world-leading publisher of scientific, technical and medical information products and services. For more than a decade, MEDai has been offering award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time and improve outcomes. For more information on MEDai, visit www.medai.com.
For More Information Contact: Lizzy Feliciano, MBA, Manager Marketing & Communications MEDai, Inc. (800) 446-3324SOURCE MEDai, Inc.
Source: PR Newswire
Related Articles
- WellCare Earns Senior Choice Gold Award for Medicare Advantage Benefits Plan
- Government Approves Lilly's Medicare Part D Patient Assistance Program
- Ninety Percent of Low-Income Seniors Surveyed Say No Problems Using Medicare Drug Benefit
- Former Health and Human Services Secretary Tommy Thompson Visits Manchester to Herald Success of New Medicare Drug Benefit
- Multimedia News Release - Web-Based Program Prepares Medical Community For Onslaught of Patient Questions About Medicare Part D
- Significant Savings for Millions of Patients With Chronic Conditions Under Medicare Rx Benefit, Says New Study
- New Medicare Drug Benefit Has Lots of Options
- Medicare Drug Benefit Letters Due
- Introduces Medicare Drug Benefit Outlooks Reports
- AVOS Introduces Medicare Drug Benefit Outlooks Reports
User Comments (0)

RSS Feeds